Response to: “Comment on ‘Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry’”
作者
Angela L. Bosma,Linde E. M. de Wijs,Michel H. Hof,Beau R. van Nieuwenhuizen,Louise A. A. Gerbens,Maritza A. Middelkamp‐Hup,DirkJan Hijnen,Phyllis I. Spuls